| 2025 |
| 05/20 | 1,477 | 1,481 | 1,453 | 1,453 | -0.89% | 130,600 | 938億7533万 | -0.89% |
| 05/19 | 1,441 | 1,467 | 1,440 | 1,466 | +0.89% | 129,400 | 947億1523万 | +0.07% |
| 05/16 | 1,445 | 1,455 | 1,433 | 1,453 | +0.83% | 79,900 | 938億7533万 | -0.55% |
| 05/15 | 1,441 | 1,447 | 1,427 | 1,441 | -1.3% | 98,500 | 931億3万 | -1.23% |
| 05/14 | 1,460 | 1,471 | 1,437 | 1,460 | -1.08% | 120,300 | 943億2758万 | +0.27% |
| 05/13 | 1,518 | 1,525 | 1,472 | 1,476 | +1.23% | 145,900 | 953億6131万 | +1.51% |
| 05/12 | （IR情報）15:30 2025年3月期決算補足資料 |
| 05/12 | （IR情報）15:30 2025年3月期決算短信〔日本基準〕(連結) |
| 05/12 | （IR情報）15:30 杏林製薬株式会社役員の異動に関するお知らせ |
| 05/12 | （IR情報）15:30 自己株式の消却に関するお知らせ |
| 05/12 | （IR情報）15:30 期末配当予想の修正(特別配当)に関するお知らせ |
| 05/12 | （IR情報）15:30 当社子会社：キョーリンリメディオ株式会社 役員の異動に関するお知らせ |
| 05/12 | （IR情報）15:30 当社子会社：キョーリン製薬グループ工場株式会社 役員の異動に関するお知らせ |
| 05/12 | 1,488 | 1,495 | 1,458 | 1,458 | -2.02% | 125,000 | 941億9837万 | +0.28% |
| 05/09 | 1,466 | 1,495 | 1,460 | 1,488 | +1.64% | 66,700 | 961億3660万 | +2.34% |
| 05/08 | 1,478 | 1,481 | 1,454 | 1,464 | -0.41% | 73,400 | 945億8601万 | +0.69% |
| 05/07 | 1,473 | 1,479 | 1,455 | 1,470 | -1.08% | 73,400 | 949億7366万 | +0.96% |
| 05/02 | 1,471 | 1,492 | 1,471 | 1,486 | +0.75% | 78,800 | 960億739万 | +1.85% |
| 05/01 | 1,470 | 1,481 | 1,463 | 1,475 | +0.07% | 88,600 | 952億9670万 | +0.82% |
| 04/30 | 1,482 | 1,485 | 1,472 | 1,474 | -0.54% | 104,400 | 952億3209万 | +0.41% |
| 04/28 | 1,491 | 1,499 | 1,482 | 1,482 | +0.34% | 110,200 | 957億4896万 | +0.68% |
| 04/25 | 1,503 | 1,505 | 1,477 | 1,477 | -1.2% | 140,700 | 954億2592万 | +0.14% |
| 04/24 | 1,508 | 1,517 | 1,487 | 1,495 | -1.52% | 171,100 | 965億8886万 | +1.01% |
| 04/23 | （IR情報）12:30 通期業績予想の修正(上方修正)に関するお知らせ |
| 04/23 | 1,488 | 1,553 | 1,481 | 1,518 | +2.85% | 653,200 | 980億7484万 | +2.29% |
| 04/22 | 1,476 | 1,487 | 1,464 | 1,476 | 0% | 52,100 | 953億6131万 | -0.74% |
| 04/21 | 1,464 | 1,476 | 1,462 | 1,476 | 0% | 40,300 | 953億6131万 | -1.07% |
| 04/18 | 1,465 | 1,479 | 1,453 | 1,476 | +1.93% | 48,500 | 953億6131万 | -1.34% |
| 04/17 | 1,446 | 1,454 | 1,431 | 1,448 | +0.49% | 69,500 | 935億5229万 | -3.53% |
| 04/16 | 1,447 | 1,449 | 1,434 | 1,441 | -0.28% | 69,600 | 931億3万 | -4.44% |
| 04/15 | 1,428 | 1,445 | 1,428 | 1,445 | +1.33% | 57,300 | 933億5846万 | -4.56% |
| 04/14 | 1,424 | 1,432 | 1,423 | 1,426 | +0.64% | 62,600 | 921億3091万 | -6.12% |
| 04/11 | 1,381 | 1,417 | 1,370 | 1,417 | -0.77% | 133,400 | 915億4944万 | -7.14% |
| 04/10 | 1,440 | 1,440 | 1,407 | 1,428 | +4.62% | 110,200 | 922億6013万 | -6.79% |
| 04/09 | 1,372 | 1,381 | 1,356 | 1,365 | -2.64% | 171,800 | 881億8983万 | -11.42% |
| 04/08 | 1,400 | 1,402 | 1,375 | 1,402 | +2.71% | 143,300 | 905億8032万 | -9.78% |
| 04/07 | 1,350 | 1,393 | 1,332 | 1,365 | -4.61% | 235,800 | 881億8983万 | -12.11% |
| 04/04 | 1,437 | 1,463 | 1,417 | 1,431 | -1.78% | 261,500 | 924億5395万 | -7.86% |
| 04/03 | 1,441 | 1,458 | 1,432 | 1,457 | -0.68% | 142,000 | 941億3376万 | -6.06% |
| 04/02 | 1,496 | 1,497 | 1,467 | 1,467 | -2.07% | 141,100 | 947億7984万 | -5.23% |
| 04/01 | 1,505 | 1,520 | 1,493 | 1,498 | -0.27% | 100,800 | 967億8268万 | -2.92% |
| 03/31 | 1,531 | 1,532 | 1,502 | 1,502 | -3.59% | 162,800 | 970億4111万 | -2.28% |
| 03/28 | 1,563 | 1,577 | 1,557 | 1,558 | -1.77% | 89,500 | 1006億5916万 | +1.76% |
| 03/27 | 1,580 | 1,586 | 1,563 | 1,586 | +0.32% | 114,300 | 1024億6818万 | +4.14% |
| 03/26 | 1,583 | 1,586 | 1,568 | 1,581 | -0.19% | 111,400 | 1021億4514万 | +4.36% |
| 03/25 | 1,560 | 1,584 | 1,557 | 1,584 | +1.8% | 167,800 | 1023億3897万 | +5.18% |
| 03/24 | 1,587 | 1,587 | 1,556 | 1,556 | -2.32% | 172,100 | 1005億2994万 | +3.87% |
| 03/21 | 1,594 | 1,603 | 1,586 | 1,593 | -0.19% | 114,600 | 1029億2044万 | +6.77% |
| 03/19 | 1,603 | 1,607 | 1,595 | 1,596 | -0.25% | 66,200 | 1031億1426万 | +7.69% |
| 03/18 | 1,597 | 1,613 | 1,597 | 1,600 | +0.19% | 103,900 | 1033億7269万 | +8.55% |
| 03/17 | 1,597 | 1,609 | 1,590 | 1,597 | +0.31% | 106,900 | 1031億7887万 | +9.01% |
| 03/14 | 1,597 | 1,610 | 1,591 | 1,592 | -0.25% | 105,400 | 1028億5583万 | +9.34% |
| 03/13 | 1,612 | 1,613 | 1,589 | 1,596 | -0.99% | 98,000 | 1031億1426万 | +10.07% |
| 03/12 | 1,598 | 1,623 | 1,595 | 1,612 | +0.75% | 196,000 | 1041億4799万 | +11.71% |
| 03/11 | 1,575 | 1,615 | 1,573 | 1,600 | +1.52% | 225,700 | 1033億7269万 | +11.42% |
| 03/10 | 1,587 | 1,592 | 1,571 | 1,576 | -1.07% | 139,200 | 1018億2210万 | +10.21% |
| 03/07 | 1,553 | 1,610 | 1,547 | 1,593 | +1.34% | 314,400 | 1029億2044万 | +11.71% |
| 03/06 | 1,618 | 1,632 | 1,548 | 1,572 | -5.19% | 518,100 | 1015億6367万 | +10.63% |
| 03/05 | 1,680 | 1,698 | 1,561 | 1,658 | -1.13% | 1,910,800 | 1071億1995万 | +17.01% |
| 03/04 | 1,677 | 1,677 | 1,677 | 1,677 | +21.79% | 122,700 | 1083億4750万 | +18.94% |
| 03/03 | （IR情報）16:00 ノバルティス社とのKRP-M223に関するグローバルライセンス契約締結について |
| 03/03 | 1,388 | 1,390 | 1,371 | 1,377 | +0.51% | 60,000 | 889億6512万 | -1.71% |
| 02/28 | 1,381 | 1,383 | 1,362 | 1,370 | -0.8% | 112,300 | 885億1287万 | -2.42% |
| 02/27 | 1,374 | 1,384 | 1,371 | 1,381 | +0.22% | 51,900 | 892億2355万 | -1.78% |
| 02/26 | （IR情報）13:00 当社子会社：キョーリン リメディオ株式会社 役員の異動に関するお知らせ |
| 02/26 | 1,360 | 1,381 | 1,360 | 1,378 | +1.77% | 98,500 | 890億2973万 | -2.2% |
| 02/25 | 1,343 | 1,359 | 1,333 | 1,354 | +0.82% | 138,300 | 874億7914万 | -4.04% |
| 02/25 | （IR情報）9:00 慢性咳嗽治療用アプリの開発について |
| 02/21 | （IR情報）11:00 「GeneSoC ウイルス前処理キット（鼻咽頭ぬぐい液用）」の新発売について |
| 02/21 | 1,339 | 1,344 | 1,331 | 1,343 | +0.15% | 119,200 | 867億6845万 | -5.09% |
| 02/20 | 1,362 | 1,362 | 1,340 | 1,341 | -1.83% | 152,700 | 866億3924万 | -5.5% |
| 02/19 | 1,372 | 1,385 | 1,361 | 1,366 | -0.36% | 56,800 | 882億5444万 | -4.01% |
| 02/18 | 1,373 | 1,389 | 1,366 | 1,371 | -0.44% | 50,200 | 885億7748万 | -3.92% |
| 02/17 | 1,386 | 1,388 | 1,376 | 1,377 | -0.65% | 45,600 | 889億6512万 | -3.71% |
| 02/14 | 1,393 | 1,394 | 1,380 | 1,386 | -0.07% | 51,400 | 895億4659万 | -3.28% |
| 02/13 | 1,371 | 1,393 | 1,371 | 1,387 | +1.84% | 69,800 | 896億1120万 | -3.48% |
| 02/12 | 1,397 | 1,397 | 1,362 | 1,362 | -1.59% | 122,900 | 879億9600万 | -5.55% |
| 02/10 | 1,387 | 1,388 | 1,376 | 1,384 | +0.8% | 57,100 | 894億1738万 | -4.35% |
| 02/07 | 1,385 | 1,401 | 1,371 | 1,373 | -0.72% | 151,500 | 887億669万 | -5.44% |
| 02/06 | 1,400 | 1,400 | 1,376 | 1,383 | -2.74% | 240,300 | 893億5277万 | -5.08% |
| 02/05 | （IR情報）15:30 2025年3月期第3四半期決算補足資料 |
| 02/05 | （IR情報）15:30 2025年3月期第3四半期決算短信〔日本基準〕(連結) |
| 02/05 | 1,430 | 1,439 | 1,422 | 1,422 | -0.49% | 118,400 | 918億7248万 | -2.6% |
| 02/04 | 1,435 | 1,446 | 1,428 | 1,429 | +0.07% | 75,500 | 923億2474万 | -2.26% |
| 02/03 | 1,462 | 1,466 | 1,424 | 1,428 | -2.99% | 200,500 | 922億6013万 | -2.39% |
| 01/31 | 1,473 | 1,473 | 1,464 | 1,472 | -0.14% | 66,400 | 951億288万 | +0.55% |
| 01/30 | 1,463 | 1,474 | 1,460 | 1,474 | +0.41% | 80,900 | 952億3209万 | +0.75% |
| 01/29 | 1,470 | 1,473 | 1,463 | 1,468 | -0.27% | 45,400 | 948億4445万 | +0.48% |
| 01/28 | 1,470 | 1,482 | 1,462 | 1,472 | +0.07% | 49,700 | 951億288万 | +0.75% |
| 01/27 | 1,457 | 1,472 | 1,457 | 1,471 | +0.96% | 46,100 | 950億3827万 | +0.75% |
| 01/24 | 1,445 | 1,457 | 1,443 | 1,457 | +1.18% | 83,400 | 941億3376万 | -0.14% |
| 01/23 | 1,442 | 1,443 | 1,435 | 1,440 | 0% | 70,900 | 930億3542万 | -1.3% |
| 01/22 | 1,450 | 1,451 | 1,440 | 1,440 | -0.14% | 52,700 | 930億3542万 | -1.37% |
| 01/21 | 1,451 | 1,454 | 1,442 | 1,442 | 0% | 32,700 | 931億6464万 | -1.3% |
| 01/20 | 1,441 | 1,455 | 1,441 | 1,442 | +0.14% | 36,000 | 931億6464万 | -1.44% |
| 01/17 | 1,444 | 1,445 | 1,437 | 1,440 | -0.41% | 61,200 | 930億3542万 | -1.64% |
| 01/16 | 1,450 | 1,454 | 1,445 | 1,446 | -0.28% | 66,000 | 934億2307万 | -1.36% |
| 01/15 | 1,446 | 1,453 | 1,445 | 1,450 | +0.07% | 57,300 | 936億8150万 | -1.16% |
| 01/14 | （IR情報）17:00 BIODOL社との疼痛治療薬候補化合物BDT272に関するオプション契約締結について |
| 01/14 | 1,450 | 1,453 | 1,439 | 1,449 | -0.34% | 82,800 | 936億1689万 | -1.29% |
| 01/10 | 1,462 | 1,462 | 1,452 | 1,454 | -0.55% | 38,200 | 939億3993万 | -1.09% |
| 01/09 | 1,480 | 1,480 | 1,462 | 1,462 | -1.28% | 72,900 | 944億5680万 | -0.54% |
| 01/08 | 1,499 | 1,501 | 1,481 | 1,481 | -1.53% | 61,800 | 956億8435万 | +0.68% |
| 01/07 | 1,510 | 1,510 | 1,491 | 1,504 | +0.07% | 73,600 | 971億7033万 | +2.24% |
| 01/06 | （IR情報）11:00 「GeneSoC 細菌前処理キット（鼻咽頭ぬぐい液用）」の新発売について |
| 01/06 | 1,505 | 1,507 | 1,495 | 1,503 | -0.13% | 92,000 | 971億572万 | +2.24% |
| 2024 |
| 12/30 | 1,498 | 1,518 | 1,497 | 1,505 | +1.28% | 107,800 | 972億3494万 | +2.45% |
| 12/27 | 1,475 | 1,489 | 1,472 | 1,486 | +1.36% | 70,800 | 960億739万 | +1.16% |
| 12/26 | 1,456 | 1,466 | 1,455 | 1,466 | +0.48% | 108,400 | 947億1523万 | -0.2% |
| 12/25 | 1,469 | 1,469 | 1,448 | 1,459 | +0.07% | 110,100 | 942億6297万 | -0.75% |
| 12/24 | 1,453 | 1,471 | 1,448 | 1,458 | +0.34% | 74,000 | 941億9837万 | -0.82% |
| 12/23 | 1,449 | 1,453 | 1,440 | 1,453 | +0.41% | 87,200 | 938億7533万 | -1.29% |
| 12/20 | 1,446 | 1,453 | 1,438 | 1,447 | +0.63% | 149,300 | 934億8768万 | -1.7% |
| 12/19 | 1,446 | 1,459 | 1,438 | 1,438 | -1.03% | 76,700 | 929億621万 | -2.38% |
| 12/18 | 1,446 | 1,464 | 1,444 | 1,453 | +0.48% | 57,000 | 938億7533万 | -1.49% |
| 12/17 | 1,452 | 1,464 | 1,444 | 1,446 | -0.41% | 87,100 | 934億2307万 | -2.03% |
| 12/16 | （IR情報）11:30 バイエル社との閉塞性睡眠時無呼吸等の新規治療薬候補化合物に関するライセンス契約締結について |
